1. Home
  2. ALT vs PKE Comparison

ALT vs PKE Comparison

Compare ALT & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • PKE
  • Stock Information
  • Founded
  • ALT 1997
  • PKE 1954
  • Country
  • ALT United States
  • PKE United States
  • Employees
  • ALT N/A
  • PKE N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • PKE Military/Government/Technical
  • Sector
  • ALT Health Care
  • PKE Industrials
  • Exchange
  • ALT Nasdaq
  • PKE Nasdaq
  • Market Cap
  • ALT 292.0M
  • PKE 352.8M
  • IPO Year
  • ALT N/A
  • PKE N/A
  • Fundamental
  • Price
  • ALT $3.83
  • PKE $18.66
  • Analyst Decision
  • ALT Strong Buy
  • PKE
  • Analyst Count
  • ALT 6
  • PKE 0
  • Target Price
  • ALT $17.40
  • PKE N/A
  • AVG Volume (30 Days)
  • ALT 3.0M
  • PKE 115.8K
  • Earning Date
  • ALT 08-12-2025
  • PKE 10-14-2025
  • Dividend Yield
  • ALT N/A
  • PKE 2.67%
  • EPS Growth
  • ALT N/A
  • PKE 4.18
  • EPS
  • ALT N/A
  • PKE 0.34
  • Revenue
  • ALT $20,000.00
  • PKE $63,456,000.00
  • Revenue This Year
  • ALT N/A
  • PKE N/A
  • Revenue Next Year
  • ALT $761,880.20
  • PKE N/A
  • P/E Ratio
  • ALT N/A
  • PKE $55.09
  • Revenue Growth
  • ALT N/A
  • PKE 16.60
  • 52 Week Low
  • ALT $2.90
  • PKE $11.97
  • 52 Week High
  • ALT $11.16
  • PKE $20.73
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • PKE 62.12
  • Support Level
  • ALT $3.35
  • PKE $18.81
  • Resistance Level
  • ALT $3.66
  • PKE $19.54
  • Average True Range (ATR)
  • ALT 0.19
  • PKE 0.59
  • MACD
  • ALT 0.07
  • PKE 0.02
  • Stochastic Oscillator
  • ALT 86.18
  • PKE 77.04

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

Share on Social Networks: